Metvix Daylight PDT in Actinic Keratosis (SESAME)

Galderma

Status: Completed

Conditions: Actinic Keratosis

Treatments: Other: Metvix

Study type: Observational

Funder types: Industry

Identifiers

NCT02674048

RD.03.SPR.104956

Details and patient eligibility

About

Prospective non-interventional study conducted in Australia, Brazil, Mexico and Europe to evaluate clinical practice with Metvix Daylight PDT in the treatment of mild to moderate actinic keratosis of the face/scalp and to assess physician and patient satisfaction.

Enrollment: 406 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Patients to whom Metvix® Daylight-PDT has already been prescribed by their physician, according to the local label;